Visit COVID-19 resources

[Skip to Content]

Brolucizumab and immunogenicity – (Eye Journal)

Apr 06
2020

Eye, Published online: 06 April 2020; doi:10.1038/s41433-020-0853-9 Brolucizumab and immunogenicity

  • 6 April 2020

Cataract surgery in patients with neovascular age related macular degeneration—examination of current practice among UK ophthalmic surgeons – (Eye Journal)

Apr 03
2020

Eye, Published online: 03 April 2020; doi:10.1038/s41433-020-0863-7 Cataract surgery in patients with neovascular age related macular degeneration—examination of current practice among UK ophthalmic surgeons

  • 3 April 2020

Ophthalmology and Optometry Patient Management during the COVID-19 Pandemic

Apr 03
2020

The COVID-19 pandemic has seriously affected the provision of eye care in primary and secondary care. Measures currently in place to protect people from acquiring the infection will undoubtedly lead to vision loss that, in normal circumstances, would have been preventable. The Royal College of Ophthalmologists and The College of Optometrists are working together to

  • 3 April 2020

NOD Audit will continue to manage services during COVID-19

Apr 01
2020

During these unprecedented times, The Royal College of Ophthalmologists will continue to deliver and manage its services to members where feasible. This includes the NOD Audit, which will continue to be managed by the NOD team and in liaison with trusts and surgeons. The collection of data, analysis and reporting of outcomes for individual surgeons and

  • 1 April 2020

Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort – (Eye Journal)

Mar 30
2020

Eye, Published online: 30 March 2020; doi:10.1038/s41433-020-0844-x Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort

  • 30 March 2020